Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

Treament interruptions in HIV therapy

August 25, 2006

Structured Treatment Interruptions Are Inferior for All Patients in Subanalyses of the SMART Study | www.medscape.com

Investigators have attempted to show that STI (Strategic Treatment Interruptions) will be safe and effective during the course of therapy of HIV infection. Unfortunately, that has been shown several times now, not to be the case.

Treatment of HIV infected patients

August 24, 2006

Similar Efficacy for 3- and 4-Drug Anti-HIV Regimens | www.medscape.com

Deleting one drug makes for better compliance in patients who have to take many medications daily. It is good to know that the 4th drug does not add much.

MK-0518 and expanded access approval

August 24, 2006

MK-0518, a Novel Integrase Inhibitor, Is Effective and Well-Tolerated | www.medscape.com

New drug in a class of drug that appears to be safe and effective. A major advance.     

Daptomycin - use in bacteremia

August 24, 2006

Daptomycin versus standard therapy for bacteremia and endocarditis caused by staphylococcus aureus | www.nejm.org

This paper provides the supporting evidence for FDA approval of daptomycin for treating bacteremia and endocarditis.   It is not particularly surprising in the results reported within.  

Cefotaxime

August 23, 2006

Orchid gets FDA okay for Cefotaxime injections | www.newkerala.com

Cefotaxime was a useful third generation cephalosporin but given its need for administration 2-3 times daily (or more) it has been supplanted by other drugs such as ceftriaxone - which is given once daily for most indications

Previous Page : 1221 to 25 of 25

Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

This author consults with leading institutions through GLG